Targeting Nerve Signals to Halt Cancer Cachexia

Imagine a clinic in 2032 where lung cancer patients maintain their strength, weight, and energy throughout therapy. This future relies on stopping

cancer cachexia

, a debilitating wasting syndrome that affects up to half of all lung cancer patients. Historically, clinicians attempted to treat this wasting with high-fat diets, assuming circulating blood factors drove the weight loss. However, a new preclinical study reveals that high-fat diets paradoxically worsen the condition. Researchers discovered that tumours lacking the Lkb1 gene produce a local chemical called prostaglandin E2 (PGE₂). This chemical signals directly to lung sensory neurons, triggering the wasting behaviour. When researchers blocked these nerve pathways or suppressed PGE₂, cachexia stopped. This suggests that the peripheral nervous system, rather than blood-borne factors, controls wasting. For future scientists, this opens a new field of neuro-oncology. You can prepare for this future by mastering key skills:

• Computational biology to model neural pathways.
• Bioinformatics to analyse genomic tumour data.
• Molecular biology to design targeted drug therapies.